- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-05-04
DOI
10.1007/s40262-018-0673-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting?
- (2018) Monica Fung et al. CLINICAL INFECTIOUS DISEASES
- Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity
- (2018) M.-P. Ledoux et al. JOURNAL DE MYCOLOGIE MEDICALE
- Isavuconazole for treatment of rare invasive fungal diseases
- (2018) Oliver A. Cornely et al. MYCOSES
- Sensibilidad in vitro de especies crípticas de Aspergillus fumigatus a isavuconazol, itraconazol y voriconazol mediante E-test
- (2018) Iker Falces-Romero et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation
- (2018) Galen M. Kabulski et al. Transplant Infectious Disease
- A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole
- (2017) Kyle John Wilby EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- New pharmacological opportunities for the treatment of invasive mould diseases
- (2017) Marie-Pierre Ledoux et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Future Research Priorities in Fungal Resistance
- (2017) Matthew W McCarthy et al. JOURNAL OF INFECTIOUS DISEASES
- Successful Isavuconazole therapy in a patient with acute invasive fungal rhinosinusitis and acquired immune deficiency syndrome
- (2016) Yasmina Ahmed et al. AMERICAN JOURNAL OF OTOLARYNGOLOGY
- Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis
- (2016) Vidmantas Petraitis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Is Effective for the Treatment of Experimental Cryptococcal Meningitis
- (2016) Nathan P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)
- (2016) Laura L. Kovanda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment
- (2016) Amit Desai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi
- (2016) Amit Desai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Isavuconazole against Rasamsonia Species
- (2016) J. Steinmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Real-Life Use of Isavuconazole in Patients Intolerant to Other Azoles: Table 1.
- (2016) Eloy E. Ordaya et al. CLINICAL INFECTIOUS DISEASES
- Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis
- (2016) Matt Shirley et al. DRUGS
- Isavuconazole absorption following oral administration in healthy subjects is comparable to intravenous dosing, and is not affected by food, or drugs that alter stomach pH
- (2016) Anne Schmitt-Hoffmann et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis
- (2016) Teclegiorgis Gebremariam et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints
- (2016) Laura L. Kovanda et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Isavuconazole: an azole active against mucormycosis
- (2016) Emmanuel Roilides et al. LANCET INFECTIOUS DISEASES
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Role of isavuconazole in the treatment of invasive fungal infections
- (2016) Dustin Wilson et al. Therapeutics and Clinical Risk Management
- Isavuconazole
- (2015) Natasha N. Pettit et al. ANNALS OF PHARMACOTHERAPY
- Pharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model
- (2015) Seyedmojtaba Seyedmousavi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Isavuconazole in a DynamicIn VitroModel of Invasive Pulmonary Aspergillosis
- (2015) Helen Box et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study
- (2015) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent
- (2015) Marisa H. Miceli et al. CLINICAL INFECTIOUS DISEASES
- In vitrosusceptibility patterns of clinically importantTrichophytonandEpidermophytonspecies against nine antifungal drugs
- (2015) Hamid Badali et al. MYCOSES
- Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent
- (2015) Jeffrey M. Rybak et al. PHARMACOTHERAPY
- Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for the Cryptococcus neoformans-Cryptococcus gattii Species Complex Using the CLSI M27-A3 Broth Microdilution Method
- (2014) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Pharmacodynamic Target Determination for Candida Species in anIn VivoMurine Disseminated Candidiasis Model
- (2013) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole (BAL4815) Pharmacodynamic Target Determination in anIn VivoMurine Model of Invasive Pulmonary Aspergillosis against Wild-Type andcyp51Mutant Isolates of Aspergillus fumigatus
- (2013) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections
- (2012) Joanne Livermore et al. Expert Opinion on Drug Metabolism & Toxicology
- Personalized prophylaxis
- (2012) P. W. COLLINS HAEMOPHILIA
- Newer antifungal agents
- (2011) Özden Türel Expert Review of Anti-Infective Therapy
- Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557
- (2009) A. Schmitt-Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Isavuconazole against Aspergillus Species and Zygomycetes According to the Methodology of the European Committee on Antimicrobial Susceptibility Testing
- (2009) S. Perkhofer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of a Novel Triazole, Isavuconazole: Mathematical Modeling, Importance of Tissue Concentrations, and Impact of Immune Status on Antifungal Effect
- (2009) P. A. Warn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species
- (2009) G. R. Thompson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species
- (2008) J. Guinea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitroactivities of isavuconazole against opportunistic filamentous and dimorphic fungi
- (2008) Gloria M. González MEDICAL MYCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started